  See all
 |
Articles: Demyelinating Disorders |
Prior Articles
Cellular and Molecular Pathways Triggering Neurodegeneration in the Spinocerebellar Ataxias
The Cerebellum, 11/12/09
Magnetic Resonance Imaging Predictors of Conversion to Multiple Sclerosis in the BENEFIT Study
Archives of Neurology, 11/11/09 Do Cannabinoids Reduce Multiple Sclerosis-Related Spasticity
The Neurologist, 11/11/09 Current and emerging treatments for amyotrophic lateral sclerosis
Neuropsychiatric Disease and Treatment, 11/11/09
Free full text
The Antiapoptotic Activity of Melatonin in Neurodegenerative Diseases
CNS Neuroscience & Therapeutics, 11/11/09 Notch1 signaling plays a role in regulating precursor differentiation during CNS remyelination
Proceedings of the National Academy of Sciences of the United States of America, 11/11/09 Review: Cyclophosphamide in multiple sclerosis: scientific rationale, history and novel treatment paradigms
Therapeutic Advances in Neurological Disorders, 11/10/09
Revew Article
Interleukin-1B and interleukin-1 receptor antagonist gene polymorphisms in Greek multiple sclerosis (MS) patients with bout-onset MS
Neurological Sciences, 11/10/09 Multiple sclerosis survival: a population-based study in Sicily
European Journal of Neurology, 11/09/09 Impact of multiple sclerosis relapses on progression diminishes with time
Neurology, 11/06/09 Free insulin-like growth factor (IGF)-1 and IGF-binding proteins-2 and -3 in serum and cerebrospinal fluid of amyotrophic lateral sclerosis patients
European Journal of Neurology, 11/05/09 A longitudinal study of cognition in nursing home residents with multiple sclerosis
Disability & Rehabilitation, 11/04/09 Serum anti-GAGA4 IgM antibodies differentiate relapsing remitting and secondary progressive multiple sclerosis from primary progressive multiple sclerosis and other neurological diseases
Journal of Neuroimmunology, 11/04/09 Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial
The Lancet, 11/03/09 Disease progression among multiple sclerosis patients before and during a disease-modifying drug program: a longitudinal population-based evaluation
Multiple Sclerosis, 11/03/09 Progressive multifocal leukoencephalopathy in individuals with minimal or occult immunosuppression
Journal of Neurology, Neurosurgery, and Psychiatry, 11/03/09 Ectopic expression of polysialylated neural cell adhesion molecule in adult macaque Schwann cells promotes their migration and remyelination potential in the central nervous system
Brain, 11/03/09 Frontal-lobe mediated behavioral dysfunction in amyotrophic lateral sclerosis
European Journal of Neurology, 11/02/09 Modulation of serum uric acid levels by inosine in patients with multiple sclerosis does not affect blood pressure
Journal of Human Hypertension, 11/02/09 Complementary and alternative medicines and dietary interventions in multiple sclerosis: What is being used in South Australia and why
Complementary Therapies in Medicine, 11/02/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Current Opinion in Neurology, Stroke, Seizure, Cephalgia, Brain Injury
more...
|
250 Available Pages
|
|
